Cardiovascular risk in diabetes: A cross-specialty approach to the clinical challenges

CME/CE Information

Learning objectives

At the conclusion of this activity, participants should be able to:

Certification

Physicians

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of CME Consultants and Strategic Consultants International. CME Consultants is accredited by the ACCME to provide
continuing medical education for physicians.

CME Consultants designates this educational activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AAPA – American Academy of Physician Assistants

This program has been reviewed and is approved for a maximum of 1.75 hours of AAPA Category 1 (Preapproved) CME credit by the Physician Assistant Review Panel. Physician Assistants should claim only those hours actually spent participating in the CME activity. This program was planned in accordance with AAPA’s CME Standards for Enduring Programs and for Commercial Support of Enduring Programs.

AANP – American Academy of Nurse Practitioners

This program has been approved for 1.75 hours of continuing education by the American Academy of Nurse Practitioners. [Program ID 0806269]

Date of initial release: August 1, 2008
Valid for credit until: August 1, 2009

Estimated time to complete the activity: 1.75 hours

 

This symposium is supported by an educational grant from
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals North America, Inc.

Syllabus disclosure statement

In direct response to the September 2004 Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, CME Consultants issued a conflict of interest policy dated January 2, 2005. The policy states that the disclosure of potential financial conflicts of interest within the last 12 months must be made and resolved prior to the date of the CME/CE/CEU activity where commercial support grants are to be used to fund the activity. The following conflicts have been managed and resolved through CME Consultants Independent Review Committee. Our intent is to assist learners in assessing the potential for bias in information that is presented during this CME/CE/CEU activity.

The Faculty is also aware that it is their responsibility to inform the audience if discussion of any non-FDA-approved uses of pharmaceuticals, medical equipment, prostheses, etc. will be included in their presentation.

Name Company Relationship
Loren A. Laine AstraZeneca
Horizon
Santarus
TAP
Consultant, Lecturer Consultant
Advisory Board
Research Support (no personal income derived), Lecture
William D. Chey AGI, Axcan, Given

Novartis, Pharmos, Prometheus, P & G, Santarus, Salix, Smart Pill, Takeda, TAP
Speakers Bureau, Honorarium
Advisory Board / Consultant, Honorarium
Benjamin D. Gold
AstraZeneca
TAP


Wyeth Research
Consultant, Honorarium
Consultant, Honorarium, Grants/Research Support, Speaker’s Bureau
Consultant
Nicholas J. Shaheen AstraZeneca

Barrx Medical, Inc., Janssen
Novartis

P&G
TAP
Honoraria for Lecturing, Research Grant Support
Research Grant Support
Honoraria for Lecturing, Research Grant Support
Research Grant Support
Honoraria for Lecturing, Research Grant Support
Prateek Sharma AstraZeneca, Olympus, TAP

Cook, Santarus, Wyeth
Honorarium (Speaker’s Bureau), Research Support
Honorarium (Speaker’s Bureau)
Alison Howe Strategic Consultants International Nothing to disclose

The planners, managers and anyone in a position to control the content of CME activities are also required to report any conflicts of interest.
The following conflicts have been managed and resolved through CME Consultants’ Independent Review Committee.